Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Primary hepatocytes and their cultures for the testing of drug-induced liver injury.

Vilas-Boas V, Cooreman A, Gijbels E, Van Campenhout R, Gustafson E, Ballet S, Annaert P, Cogliati B, Vinken M.

Adv Pharmacol. 2019;85:1-30. doi: 10.1016/bs.apha.2018.08.001. Epub 2018 Sep 1.

PMID:
31307583
2.

Industrial, Biocide, and Cosmetic Chemical Inducers of Cholestasis.

Vilas-Boas V, Gijbels E, Cooreman A, Van Campenhout R, Gustafson E, Leroy K, Vinken M.

Chem Res Toxicol. 2019 Jul 15;32(7):1327-1334. doi: 10.1021/acs.chemrestox.9b00148. Epub 2019 Jun 18.

PMID:
31243985
3.

Connexin and Pannexin (Hemi)Channels: Emerging Targets in the Treatment of Liver Disease.

Cooreman A, Van Campenhout R, Ballet S, Annaert P, Van Den Bossche B, Colle I, Cogliati B, Vinken M.

Hepatology. 2019 Mar;69(3):1317-1323. doi: 10.1002/hep.30306. Epub 2019 Feb 23. Review.

PMID:
30300925
4.

Annual Conferences of the European, Middle Eastern and African Society for Biopreservation and Biobanking (ESBB): overview of 2011 and preview of 2012.

Chabannon C, Doran P, Hofman P, Seberg O, Cinotti S, Bledsoe M, Deigner HP, Koschorreck J, Dagher G, Cooreman A, De Blasio P, Riegman P, Hewitt R.

Biopreserv Biobank. 2012 Oct;10(5):407-15. doi: 10.1089/bio.2012.1052. No abstract available.

PMID:
24845041
5.

Cyclic nucleotide signalling: a molecular approach to drug discovery for Alzheimer's disease.

McPhee I, Gibson LC, Kewney J, Darroch C, Stevens PA, Spinks D, Cooreman A, MacKenzie SJ.

Biochem Soc Trans. 2005 Dec;33(Pt 6):1330-2. Review.

PMID:
16246111

Supplemental Content

Loading ...
Support Center